<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35925073</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-7099</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Innere Medizin (Heidelberg, Germany)</Title><ISOAbbreviation>Inn Med (Heidelb)</ISOAbbreviation></Journal><ArticleTitle>[Pulmonary manifestations in long COVID].</ArticleTitle><Pagination><StartPage>819</StartPage><EndPage>829</EndPage><MedlinePgn>819-829</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00108-022-01371-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulmonary manifestations are very common sequelae after severe acute respiratory syndrome coronavirus type&#xa0;2 (SARS-CoV-2) infections, which are summarized under the term long COVID (coronavirus disease) syndrome.</AbstractText><AbstractText Label="AIM/METHODS" NlmCategory="OBJECTIVE">This article summarizes the current literature on pulmonary manifestations with a&#xa0;focus on expert opinions and recommendations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After chronic fatigue, dyspnea is the most common symptom in patients with long COVID syndrome. Pathological findings are mainly found after a&#xa0;severe acute course of COVID-19 and include radiological changes with characteristics of interstitial lung diseases, restrictive ventilation patterns and limitations in diffusion capacity as the most common pathological finding. Although both symptoms and pathological pulmonary alterations improve over time, some patients may still suffer from abnormalities months after the acute infection. The relevance of the pathological findings, as well as the involvement of functional respiratory limitations, cardiopulmonary deconditioning, non-somatic causes and pre-existing lung diseases, is currently unclear. The advanced diagnostic assessment thus focusses on high-risk patients and includes, in addition to imaging and pulmonary function tests, a&#xa0;cardiopulmonary exercise test and, if the findings are unclear, an echocardiography to diagnose a&#xa0;pulmonary vascular component. The therapeutic options currently include treatment of the underlying causes of the symptoms (e.g. interstitial lung diseases, cough) according to the respective guidelines and rehabilitation measures.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The current knowledge about pulmonary manifestations in long COVID patients is constantly being expanded, but due to limited availability of clinical trials, there are still no evidence-based guidelines for the diagnosis and therapy of pulmonary manifestations in long COVID syndrome.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sommer</LastName><ForeName>Natascha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-Universit&#xe4;t, Klinikstr.&#xa0;33, 35390, Gie&#xdf;en, Deutschland. natascha.sommer@innere.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmeck</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin mit Schwerpunkt Pneumologie, Schlaf- und Intensivmedizin, Sektion f&#xfc;r Atemwegsinfektionen, Philipps-Universit&#xe4;t Marburg, Marburg, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut f&#xfc;r Lungenforschung, Universities of Giessen and Marburg Lung Center (UGMLC), Mitglied des Deutschen Zentrums f&#xfc;r Lungenforschung (DZL) und des Deutschen Zentrums f&#xfc;r Infektionsforschung (DZIF), Philipps-Universit&#xe4;t Marburg, Marburg, Deutschland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Pulmonale Manifestationen bei Long-COVID.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Inn Med (Heidelb)</MedlineTA><NlmUniqueID>9918384885306676</NlmUniqueID><ISSNLinking>2731-7080</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="Y">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">HINTERGRUND: Pulmonale Manifestationen sind sehr h&#xe4;ufige Folgeerscheinungen nach einer Severe-acute-respiratory-syndrome-coronavirus-type-2(SARS-CoV-2)-Infektion, die unter dem Begriff Long-COVID-Syndrom (COVID &#x201e;coronavirus disease&#x201c;) zusammengefasst werden.</AbstractText><AbstractText Label="ZIEL UND METHODEN" NlmCategory="UNASSIGNED">Zusammenfassung der aktuellen Literatur zu den pulmonalen Manifestationen mit einem Fokus auf Expertenempfehlungen.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">Dyspnoe ist nach der chronischen Fatigue das h&#xe4;ufigste Symptom bei Patienten mit Long-COVID-Syndrom. Auff&#xe4;llige Befunde finden sich vor allem nach schwerem akutem COVID-19-Verlauf und beinhalten radiologische Ver&#xe4;nderungen im Sinne interstitieller Lungenerkrankungen, restriktive lungenfunktionelle Befunde und Einschr&#xe4;nkungen der Diffusionskapazit&#xe4;t als h&#xe4;ufigsten pathologischen Befund. Obwohl sich sowohl Beschwerden als auch pathologische pulmonale Befunde im Verlauf bessern, k&#xf6;nnen einige Patienten noch Monate nach der akuten Infektion unter Auff&#xe4;lligkeiten leiden. Dabei ist die Relevanz der pathologischen Befunde sowie eine Beteiligung funktioneller respiratorischer Einschr&#xe4;nkungen, einer kardiopulmonalen Dekonditionierung, nichtsomatischer Ursachen und vorbestehender Erkrankungen aktuell unklar. Die diagnostische Abkl&#xe4;rung fokussiert entsprechend auf Risikopatienten und schlie&#xdf;t neben einer bildgebenden und lungenfunktionellen Abkl&#xe4;rung eine Belastungsuntersuchung und bei unklaren Befunden eine Echokardiographie zur Diagnose einer pulmonalvaskul&#xe4;ren Komponente ein. Die therapeutischen M&#xf6;glichkeiten beinhalten aktuell die leitliniengerechte Therapie von Ursachen der Beschwerden (beispielsweise interstitielle Lungenerkrankungen, Husten) und Rehabilitationsma&#xdf;nahmen.</AbstractText><AbstractText Label="SCHLUSSFOLGERUNG" NlmCategory="UNASSIGNED">Das aktuelle Wissen zum Krankheitsbild wird st&#xe4;ndig erweitert, allerdings existieren aufgrund mangelnder Studienlage noch keine evidenzbasierten Leitlinien zur Diagnostik und Therapie pulmonaler Manifestationen beim Long-COVID-Syndrom.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cough</Keyword><Keyword MajorTopicYN="N">Dyspnea</Keyword><Keyword MajorTopicYN="N">Long COVID/physiopathology</Keyword><Keyword MajorTopicYN="N">Lung diseases, interstitial</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus type&#xa0;2 (SARS-CoV-2)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35925073</ArticleId><ArticleId IdType="pmc">PMC9261889</ArticleId><ArticleId IdType="doi">10.1007/s00108-022-01371-3</ArticleId><ArticleId IdType="pii">10.1007/s00108-022-01371-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The road to addressing Long Covid. Science. 2021;373:491&#x2013;493. doi: 10.1126/science.abg7113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell AM, et al. European respiratory society statement on long COVID-19 follow-up. Eur Respir&#xa0;J. 2022 doi: 10.1183/13993003.02174-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02174-2021</ArticleId><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Leber A, Jawad MY, et al. Registered clinical trials investigating treatment of long COVID: a&#xa0;scoping review and recommendations for research. Infect Dis. 2022;54:467&#x2013;477. doi: 10.1080/23744235.2022.2043560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2043560</ArticleId><ArticleId IdType="pmc">PMC8935463</ArticleId><ArticleId IdType="pubmed">35282780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman DG, Badal T, King GG, et al. Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19&#xa0;patients. Eur Respir&#xa0;J. 2021 doi: 10.1183/13993003.03263-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03263-2020</ArticleId><ArticleId IdType="pmc">PMC7651835</ArticleId><ArticleId IdType="pubmed">33154026</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of post COVID-19 condition or long COVID: a&#xa0;meta-analysis and systematic review. J&#xa0;Infect Dis. 2022 doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, Villacreses R, Nagpal P, et al. Quantitative chest CT assessment of small airways disease in post-acute SARS-coV&#x2011;2 infection. Radiology. 2022 doi: 10.1148/radiol.212170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Darawshy F, Rmeileh AA, Kuint R, et al. Residual symptoms, lung function, and imaging findings in patients recovering from SARS-CoV&#x2011;2 infection. Intern Emerg Med. 2022 doi: 10.1007/s11739-022-02950-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-02950-w</ArticleId><ArticleId IdType="pmc">PMC8889872</ArticleId><ArticleId IdType="pubmed">35235130</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9:107&#x2013;116. doi: 10.1016/S2213-2600(20)30407-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P, Luppi F, Rebora P, et al. One-year pulmonary impairment after severe COVID-19: a&#xa0;prospective, multicenter follow-up study. Respir Res. 2022;23:65. doi: 10.1186/s12931-022-01994-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01994-y</ArticleId><ArticleId IdType="pmc">PMC8934910</ArticleId><ArticleId IdType="pubmed">35313890</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-De-Las-Penas C, Guijarro C, Plaza-Canteli S, et al. Prevalence of post-COVID-19 cough one year after SARS-coV-2 infection: a multicenter study. Am J Physiol. 2021;199:249&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Respir J. 2015;46:903&#x2013;975. doi: 10.1183/13993003.01032-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01032-2015</ArticleId><ArticleId IdType="pubmed">26318161</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Chen M, Collier GJ, et al. Hyperpolarized (129)Xe MRI abnormalities in dyspneic patients 3 months after COVID-19 pneumonia: preliminary results. Radiology. 2021;301:E353&#x2013;E360. doi: 10.1148/radiol.2021210033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210033</ArticleId><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation> Guidelines. NC&#x2011;T. https://www.covid19treatmentguidelines.nih.gov/therapies/antithrombotic-therapy/. Zugegriffen: 20. Mai 2022</Citation></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4&#xa0;months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir&#xa0;J. 2021 doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs JK, Oqueka T, Harbaum L, et al. Organ-specific sequelae of COVID-19 in adults. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65:462&#x2013;470. doi: 10.1007/s00103-022-03513-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-022-03513-2</ArticleId><ArticleId IdType="pmc">PMC8925979</ArticleId><ArticleId IdType="pubmed">35294563</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a&#xa0;cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2&#xa0;years after surviving hospitalisation with COVID-19: a&#xa0;longitudinal cohort study. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, et al. S1 Guideline Post-COVID/Long-COVID. Pneumologie. 2021;75:869&#x2013;900. doi: 10.1055/a-1551-9734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MCH, Skaarup KG, Lind JN, et al. Recovery of cardiac function following COVID-19&#x2014;ECHOVID-19: a&#xa0;prospective longitudinal cohort study. Eur J Heart Fail. 2021;23:1903&#x2013;1912. doi: 10.1002/ejhf.2347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2347</ArticleId><ArticleId IdType="pmc">PMC8652600</ArticleId><ArticleId IdType="pubmed">34514713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a&#xa0;systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022 doi: 10.1183/16000617.0185-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Munker D, Veit T, Barton J, et al. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4&#xa0;months after COVID-19 according to disease severity. Infection. 2022;50:157&#x2013;168. doi: 10.1007/s15010-021-01669-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01669-8</ArticleId><ArticleId IdType="pmc">PMC8318328</ArticleId><ArticleId IdType="pubmed">34322859</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18:799&#x2013;806. doi: 10.1513/AnnalsATS.202008-1002OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, et al. Long COVID: post-acute sequelae of COVID-19 with a&#xa0;cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi R, Coppi F, Monopoli DE, et al. Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors. Cardiol J. 2022;29:163&#x2013;165. doi: 10.5603/CJ.a2021.0159.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0159</ArticleId><ArticleId IdType="pmc">PMC8890407</ArticleId><ArticleId IdType="pubmed">34897638</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro&#xa0;L, Falsetti&#xa0;L, Zaccone&#xa0;V et al (2022) Impaired endothelial function in convalescent phase of COVID-19: a&#xa0;3&#xa0;month follow up observational prospective study. J&#xa0;Clin Med. 10.3390/jcm11071774</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8999944</ArticleId><ArticleId IdType="pubmed">35407382</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir&#xa0;J. 2021 doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Thibeault C, Doellinger F, et al. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12&#xa0;months. Respir Med. 2022;191:106709. doi: 10.1016/j.rmed.2021.106709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106709</ArticleId><ArticleId IdType="pmc">PMC8632363</ArticleId><ArticleId IdType="pubmed">34871947</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kampen JJA, Van De Vijver D, Fraaij PLA, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Nat Commun. 2021;12:267. doi: 10.1038/s41467-020-20568-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20568-4</ArticleId><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a&#xa0;prospective study. Lancet Respir Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>